Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Capsulin OAD
- Development stage
- Unknown
- Lead developer
- Diabetology
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Administration
- Oral
01
Overview
Capsulin OAD is an oral formulation of recombinant human insulin developed by Diabetology Limited for the treatment of Type 2 Diabetes Mellitus (T2DM). The drug utilizes the proprietary Axcess™ oral delivery technology, which employs enteric-coated capsules containing pharmaceutical excipients that facilitate the absorption of insulin in the small intestine. By delivering insulin orally, the drug aims to mimic the physiological portal delivery of insulin, activating insulin receptors to improve glycemic control, reduce HbA1c, fasting plasma glucose, and triglycerides. Phase 2b clinical studies demonstrated that Capsulin OAD was safe and effective, with no confirmed treatment-linked hypoglycemic events. It is currently in Phase 3 development and is distinguished from Capsulin IR, which is intended for insulin replacement in Type 1 and late-stage Type 2 diabetes.
- Brand names
- Capsulin OAD
- Other names
- CapsulinOral insulin
02
Targets
IGF-1R (Insulin-like growth factor 1 receptor)INSR (Insulin receptor)
Beyond the preview
Go deeper on Capsulin OAD.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Capsulin OAD.